Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer

Acquisition of resistance to gemcitabine is a challenging clinical and biological hallmark property of refractory pancreatic cancer. Here, we investigated whether glycogen synthase kinase (GSK)‐3β, an emerging therapeutic target in various cancer types, is mechanistically involved in acquired resist...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Sci
Huvudupphovsmän: Uehara, Masahiro, Domoto, Takahiro, Takenaka, Satoshi, Bolidong, Dilireba, Takeuchi, Osamu, Miyashita, Tomoharu, Minamoto, Toshinari
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734171/
https://ncbi.nlm.nih.gov/pubmed/32986894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14668
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk